United States Immune Check Point Inhibitors Market Report & Forecast 2021-2027

United States Immune Check Point Inhibitors Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Immune Check Point Inhibitors Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Immune Check Point Inhibitors Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Immune Check Point Inhibitors Overall Market Size
2.1 United States Immune Check Point Inhibitors Market Size: 2021 VS 2027
2.2 United States Immune Check Point Inhibitors Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immune Check Point Inhibitors Players in United States Market
3.2 Top United States Immune Check Point Inhibitors Companies Ranked by Revenue
3.3 United States Immune Check Point Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Immune Check Point Inhibitors Companies in United States Market, by Revenue in 2020
3.5 Companies Immune Check Point Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immune Check Point Inhibitors Players in United States Market
3.6.1 List of Tier 1 Immune Check Point Inhibitors Companies in United States
3.6.2 List of Tier 2 and Tier 3 Immune Check Point Inhibitors Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Immune Check Point Inhibitors Market Size Markets, 2021 & 2027
4.1.2 CLTA-4 Inhibitors
4.1.3 PD-1 & PD-L1 Inhibitor
4.2 By Type - United States Immune Check Point Inhibitors Revenue & Forecasts
4.2.1 By Type - United States Immune Check Point Inhibitors Revenue, 2016-2021
4.2.2 By Type - United States Immune Check Point Inhibitors Revenue, 2022-2027
4.2.3 By Type - United States Immune Check Point Inhibitors Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Immune Check Point Inhibitors Market Size, 2021 & 2027
5.1.2 Lung Cancer
5.1.3 Blood Cancer
5.1.4 Renal Cancer
5.1.5 Bladder Cancer
5.1.6 Melanoma
5.1.7 Hodgkin Lymphoma
5.2 By Application - United States Immune Check Point Inhibitors Revenue & Forecasts
5.2.1 By Application - United States Immune Check Point Inhibitors Revenue, 2016-2021
5.2.2 By Application - United States Immune Check Point Inhibitors Revenue, 2022-2027
5.2.3 By Application - United States Immune Check Point Inhibitors Revenue Market Share, 2016-2027
6 Immune Check Point Inhibitors Companies Profiles
6.1 Bristol-Myers Squibb Company
6.1.1 Bristol-Myers Squibb Company Company Details
6.1.2 Bristol-Myers Squibb Company Business Overview
6.1.3 Bristol-Myers Squibb Company Immune Check Point Inhibitors Introduction
6.1.4 Bristol-Myers Squibb Company Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.1.5 Bristol-Myers Squibb Company Recent Developments
6.2 AstraZeneca
6.2.1 AstraZeneca Company Details
6.2.2 AstraZeneca Business Overview
6.2.3 AstraZeneca Immune Check Point Inhibitors Introduction
6.2.4 AstraZeneca Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.2.5 AstraZeneca Recent Developments
6.3 Merck & Co
6.3.1 Merck & Co Company Details
6.3.2 Merck & Co Business Overview
6.3.3 Merck & Co Immune Check Point Inhibitors Introduction
6.3.4 Merck & Co Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.3.5 Merck & Co Recent Developments
6.4 Pfizer, Inc
6.4.1 Pfizer, Inc Company Details
6.4.2 Pfizer, Inc Business Overview
6.4.3 Pfizer, Inc Immune Check Point Inhibitors Introduction
6.4.4 Pfizer, Inc Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.4.5 Pfizer, Inc Recent Developments
6.5 F. Hoffmann-La Roche Ltd
6.5.1 F. Hoffmann-La Roche Ltd Company Details
6.5.2 F. Hoffmann-La Roche Ltd Business Overview
6.5.3 F. Hoffmann-La Roche Ltd Immune Check Point Inhibitors Introduction
6.5.4 F. Hoffmann-La Roche Ltd Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.5.5 F. Hoffmann-La Roche Ltd Recent Developments
6.6 Incyte Corporation
6.6.1 Incyte Corporation Company Details
6.6.2 Incyte Corporation Business Overview
6.6.3 Incyte Corporation Immune Check Point Inhibitors Introduction
6.6.4 Incyte Corporation Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.6.5 Incyte Corporation Recent Developments
6.7 NewLink Genetics Corporation
6.7.1 NewLink Genetics Corporation Company Details
6.7.2 NewLink Genetics Corporation Business Overview
6.7.3 NewLink Genetics Corporation Immune Check Point Inhibitors Introduction
6.7.4 NewLink Genetics Corporation Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.7.5 NewLink Genetics Corporation Recent Developments
6.8 Celldex Therapeutics, Inc
6.8.1 Celldex Therapeutics, Inc Company Details
6.8.2 Celldex Therapeutics, Inc Business Overview
6.8.3 Celldex Therapeutics, Inc Immune Check Point Inhibitors Introduction
6.8.4 Celldex Therapeutics, Inc Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.8.5 Celldex Therapeutics, Inc Recent Developments
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Company Details
6.9.2 GlaxoSmithKline Business Overview
6.9.3 GlaxoSmithKline Immune Check Point Inhibitors Introduction
6.9.4 GlaxoSmithKline Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.9.5 GlaxoSmithKline Recent Developments
6.10 Seattle Genetics, Inc.
6.10.1 Seattle Genetics, Inc. Company Details
6.10.2 Seattle Genetics, Inc. Business Overview
6.10.3 Seattle Genetics, Inc. Immune Check Point Inhibitors Introduction
6.10.4 Seattle Genetics, Inc. Immune Check Point Inhibitors Revenue in United States Market (2016-2021)
6.10.5 Seattle Genetics, Inc. Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Immune Check Point Inhibitors Market Opportunities & Trends in United States Market
Table 2. Immune Check Point Inhibitors Market Drivers in United States Market
Table 3. Immune Check Point Inhibitors Market Restraints in United States Market
Table 4. Key Players of Immune Check Point Inhibitors in United States Market
Table 5. Top Immune Check Point Inhibitors Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Immune Check Point Inhibitors Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Immune Check Point Inhibitors Revenue Share by Companies, 2016-2021
Table 8. Companies Immune Check Point Inhibitors Product Type
Table 9. List of Tier 1 Immune Check Point Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Immune Check Point Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Immune Check Point Inhibitors Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Immune Check Point Inhibitors Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Immune Check Point Inhibitors Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Immune Check Point Inhibitors Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Immune Check Point Inhibitors Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Immune Check Point Inhibitors Revenue (US$, Mn), 2022-2027
Table 17. Bristol-Myers Squibb Company Company Details
Table 18. Bristol-Myers Squibb Company Business Overview
Table 19. Bristol-Myers Squibb Company Immune Check Point Inhibitors Product
Table 20. Bristol-Myers Squibb Company Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Bristol-Myers Squibb Company Recent Developments
Table 22. AstraZeneca Company Details
Table 23. AstraZeneca Business Overview
Table 24. AstraZeneca Immune Check Point Inhibitors Product
Table 25. AstraZeneca Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. AstraZeneca Recent Developments
Table 27. Merck & Co Company Details
Table 28. Merck & Co Business Overview
Table 29. Merck & Co Immune Check Point Inhibitors Product
Table 30. Merck & Co Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Merck & Co Recent Developments
Table 32. Pfizer, Inc Company Details
Table 33. Pfizer, Inc Business Overview
Table 34. Pfizer, Inc Immune Check Point Inhibitors Product
Table 35. Pfizer, Inc Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Pfizer, Inc Recent Developments
Table 37. F. Hoffmann-La Roche Ltd Company Details
Table 38. F. Hoffmann-La Roche Ltd Business Overview
Table 39. F. Hoffmann-La Roche Ltd Immune Check Point Inhibitors Product
Table 40. F. Hoffmann-La Roche Ltd Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. F. Hoffmann-La Roche Ltd Recent Developments
Table 42. Incyte Corporation Company Details
Table 43. Incyte Corporation Business Overview
Table 44. Incyte Corporation Immune Check Point Inhibitors Product
Table 45. Incyte Corporation Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Incyte Corporation Recent Developments
Table 47. NewLink Genetics Corporation Company Details
Table 48. NewLink Genetics Corporation Business Overview
Table 49. NewLink Genetics Corporation Immune Check Point Inhibitors Product
Table 50. NewLink Genetics Corporation Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. NewLink Genetics Corporation Recent Developments
Table 52. Celldex Therapeutics, Inc Company Details
Table 53. Celldex Therapeutics, Inc Business Overview
Table 54. Celldex Therapeutics, Inc Immune Check Point Inhibitors Product
Table 55. Celldex Therapeutics, Inc Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Celldex Therapeutics, Inc Recent Developments
Table 57. GlaxoSmithKline Company Details
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Immune Check Point Inhibitors Product
Table 60. GlaxoSmithKline Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. GlaxoSmithKline Recent Developments
Table 62. Seattle Genetics, Inc. Company Details
Table 63. Seattle Genetics, Inc. Business Overview
Table 64. Seattle Genetics, Inc. Immune Check Point Inhibitors Product
Table 65. Seattle Genetics, Inc. Immune Check Point Inhibitors Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Seattle Genetics, Inc. Recent Developments
List of Figures
Figure 1. Immune Check Point Inhibitors Segment by Type
Figure 2. Immune Check Point Inhibitors Segment by Application
Figure 3. United States Immune Check Point Inhibitors Market Overview: 2020
Figure 4. United States Immune Check Point Inhibitors Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Immune Check Point Inhibitors Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Immune Check Point Inhibitors Revenue in 2020
Figure 7. By Type - United States Immune Check Point Inhibitors Revenue Market Share, 2016-2027
Figure 8. By Application - United States Immune Check Point Inhibitors Revenue Market Share, 2016-2027
Figure 9. Bristol-Myers Squibb Company Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. AstraZeneca Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Merck & Co Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Pfizer, Inc Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. F. Hoffmann-La Roche Ltd Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Incyte Corporation Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. NewLink Genetics Corporation Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Celldex Therapeutics, Inc Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. GlaxoSmithKline Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Seattle Genetics, Inc. Immune Check Point Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs